Fred Hutch researchers launch free online tool to assess CRC risk

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

The incidence of multiple cancer types in people under the age of 50 has been rising, with early-onset cancers now contributing to nearly 15,000 excess cases of cancer in the U.S. annually.

March 27, 2026

Vol.52 No.12

By W. Kimryn Rathmell

Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.

March 27, 2026

Vol.52 No.12

By Richard M. Goldberg

Clinical

Colorectal cancer is now the leading cause of cancer death in patients under 50
Why aren’t 45-year-olds getting their recommended CRC screenings?

Three decades ago, colorectal cancer was the fifth leading cause of cancer death in patients under 50 years old. For a physician treating the average 45-year-old, colorectal cancer was not a diagnosis that immediately came to mind.

March 27, 2026

Vol.52 No.12

By Sara Willa Ernst

Early-onset colorectal cancer demands a new research playbook

Colorectal cancer is no longer a disease confined to older adults.

Shadman, Venur named deputy CMOs and endowed chairs at Fred Hutch

Fred Hutch has appointed Mazyar Shadman and Vyshak Alva Venur as deputy chief medical officers, effective April 1.

March 20, 2026

Vol.52 No.11

Clinical Roundup

Novel antibody blocks Epstein-Barr virus, Fred Hutch study finds

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus, a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions.

March 13, 2026

Vol.52 No.10

Fred Hutch researchers launch free online tool to assess CRC risk

YOU MAY BE INTERESTED IN

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

Colorectal cancer is now the leading cause of cancer death in patients under 50
Why aren’t 45-year-olds getting their recommended CRC screenings?

Early-onset colorectal cancer demands a new research playbook

Shadman, Venur named deputy CMOs and endowed chairs at Fred Hutch

Novel antibody blocks Epstein-Barr virus, Fred Hutch study finds

Renew today!

Subscriber content

Never miss an issue!

Login

Fred Hutch researchers launch free online tool to assess CRC risk

YOU MAY BE INTERESTED IN

Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients

In the era of immunotherapy, response rate alone fails to predict true patient benefitRegulators must adapt

Colorectal cancer is now the leading cause of cancer death in patients under 50Why aren’t 45-year-olds getting their recommended CRC screenings?

Early-onset colorectal cancer demands a new research playbook

Shadman, Venur named deputy CMOs and endowed chairs at Fred Hutch

Novel antibody blocks Epstein-Barr virus, Fred Hutch study finds

Never miss an issue!

Login

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

Colorectal cancer is now the leading cause of cancer death in patients under 50
Why aren’t 45-year-olds getting their recommended CRC screenings?